Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) will be issuing its quarterly earnings data after the market closes on Monday, August 7th. Analysts expect the company to announce earnings of ($0.78) per share for the quarter.
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) last issued its earnings results on Monday, May 15th. The company reported ($1.27) earnings per share for the quarter, topping the consensus estimate of ($1.36) by $0.09. On average, analysts expect Tonix Pharmaceuticals Holding Corp. to post $-3.93 EPS for the current fiscal year and $-3.48 EPS for the next fiscal year.
Tonix Pharmaceuticals Holding Corp. (TNXP) opened at 3.69 on Friday. The firm’s market capitalization is $27.62 million. Tonix Pharmaceuticals Holding Corp. has a 12 month low of $3.30 and a 12 month high of $28.00. The firm has a 50-day moving average price of $4.23 and a 200 day moving average price of $3.09.
In other news, Director Ernest Mario sold 6,105 shares of the business’s stock in a transaction dated Friday, June 30th. The stock was sold at an average price of $4.28, for a total value of $26,129.40. Following the sale, the director now directly owns 63,073 shares in the company, valued at $269,952.44. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Seth Lederman purchased 20,000 shares of the business’s stock in a transaction dated Tuesday, June 20th. The stock was purchased at an average price of $4.22 per share, for a total transaction of $84,400.00. Following the completion of the acquisition, the chief executive officer now owns 7,912 shares of the company’s stock, valued at $33,388.64. The disclosure for this purchase can be found here. Over the last 90 days, insiders bought 30,000 shares of company stock worth $128,050. Corporate insiders own 4.00% of the company’s stock.
Separately, Aegis initiated coverage on Tonix Pharmaceuticals Holding Corp. in a report on Monday, June 26th. They issued a “buy” rating and a $10.00 price target on the stock.
Receive News & Ratings for Tonix Pharmaceuticals Holding Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tonix Pharmaceuticals Holding Corp. and related companies with MarketBeat.com's FREE daily email newsletter.
